INS and diabetes mellitus: Metformin's use for DM treatment is generally considered to be a first-line option due to affordability, accessibility, and effectiveness in lowering A1C, as evidenced here with patients having taken metformin having reduced values when compared to sulfonylureas and short-acting insulins with differences of 0.1% and 0.56%, respectively [22].